Yasho Industries Q4 FY26: Growth With Discipline, Even as Margins Reset

Yasho Industries closed Q4 FY26 with the kind of finish investors like to see: higher scale, stronger profitability, and clearer visibility on the next phase of capacity-led growth. Consolidated revenue from operations rose to Rs 246.26 crore in Q4 FY26 from Rs 184.81 crore a year ago. Total revenue, including other income, grew 33.03 percent year on year to Rs 246.72 crore. EBITDA increased 23.73 percent to Rs 44.72 crore, and profit after tax more than doubled to Rs 12.26 crore.

For the full year, the company reported consolidated revenue from operations of Rs 830.03 crore, up from Rs 675.64 crore in FY25. EBITDA rose to Rs 144.46 crore from Rs 119.40 crore. PAT grew sharply to Rs 25.26 crore from Rs 6.11 crore. The step-up in earnings mattered even more because FY26 was not a clean macro year. Management flagged tariff-related disruptions, geopolitical tensions, supply chain volatility, and higher raw material costs. Yet the company kept pushing execution: investing in R and D, commercializing two new manufacturing lines, and securing a long-term customer-funded engagement with a multinational company.

The quarter in numbers, and what changed beneath the surface

Q4 FY26 showed solid operating momentum, but it also revealed where the pressure points were. Gross profit margin fell to 38.98 percent in Q4 FY26 from 43.27 percent in Q4 FY25. Despite that, EBITDA margin held at 18.16 percent, only moderately lower than 19.56 percent last year, supported by scale and execution.

Sequentially, the quarter looked even stronger. Total revenue rose 22.2 percent quarter on quarter versus Q3 FY26, while EBITDA climbed 33.01 percent. PAT expanded sharply from Rs 4.50 crore in Q3 FY26 to Rs 12.26 crore in Q4 FY26. Finance costs also declined year on year in the quarter to Rs 14.23 crore from Rs 15.13 crore, supporting the improvement in profit before tax.

The full-year picture was consistent with this trajectory. FY26 EBITDA margin stood at 17.40 percent. Management commentary highlighted a year of operational focus despite external headwinds. Importantly, the company ended FY26 with better debt servicing metrics and a clear capex roadmap that is intended to be funded through internal accruals.

Note: Rs crore computed from Rs lakhs disclosed in the income statement.

Mix, footprint, and the business that is carrying scale

Yasho operates across two business categories: industrial chemicals and consumer chemicals, with industrial forming the bulk of the base. In Q4 FY26, industrial chemicals contributed 88 percent of revenue, up from 85 percent in Q4 FY25. Consumer chemicals fell to 12 percent from 15 percent.

Geographically, the quarter reflected a meaningful swing toward the domestic market. International revenue was 58 percent in Q4 FY26 compared with 67 percent in Q4 FY25, while domestic rose to 42 percent from 33 percent. This shift can matter for near-term volatility, since export-oriented chemical businesses often see sharper swings from geopolitics, tariffs, or shipping disruptions. Management explicitly cited tariff-related disruptions and supply chain volatility during FY26, making the quarter’s mix shift a relevant datapoint.

For the full year, the business remained export-heavy but slightly less so than FY25. International contributed 62 percent in FY26, down from 65 percent in FY25, while domestic improved to 38 percent from 35 percent. Category-wise, industrial chemicals were 87 percent in FY26 versus 83 percent in FY25. The story is not diversification away from industrial, but a gradual broadening of the base while industrial continues to drive scale.

This mix progression fits the way Yasho describes itself: a specialty chemicals manufacturer producing high-performance ingredients across industrial and consumer applications, including lubricant additives and rubber chemicals. The portfolio is broad, with 140 plus products, and the company serves a 50 plus country footprint. In FY26, the business also continued to position itself as an emerging global specialty chemicals partner to multinational customers.

Capex, capacity, and why utilization is the next lever

The bigger driver of the FY27 and FY28 debate is capacity and execution, not only quarterly performance. Management said FY26 operated at about 60 percent utilization and is targeting more than 75 percent in FY27. The company expects higher utilization to improve EBITDA margins by 2 to 3 percentage points through better economies of scale and efficiency gains.

The infrastructure backdrop matters here. Yasho has two manufacturing plants.

The Pakhajan plant is spread across 42 acres and currently uses only 25 percent of the land parcel. The company said this allows 20 to 25 percent growth without additional infrastructure capex. In FY26, capex incurred at Pakhajan was Rs 65.90 crore. At optimal utilization, the existing plants have the potential to generate peak revenue of Rs 700 to 750 crore.

The Vapi plant is described as a versatile multi-functional unit built to support varied chemistries. It is strategically located near key ports, supporting global customers and delivery timelines. FY26 capex incurred at Vapi was Rs 9.3 crore. At optimal utilization, Vapi has potential peak revenue of Rs 650 to 700 crore.

Two points stand out. First, the peak revenue potential across plants indicates headroom versus FY26 revenue of Rs 830.03 crore, suggesting the story is not only about adding assets but also about sweating existing ones. Second, the company is investing in capabilities that can move it up the value chain. In FY26, management referenced continued investments in R and D and commercialization of two new manufacturing lines focused on high-growth product categories.

R and D is a central part of that thesis. The company has more than 50 in-house researchers and operates dedicated R and D facilities in Vapi and Pakhan, spread across 25,000 plus sq ft. The presentation listed multiple certifications including ISO, FSSAI, STAR KOSHER, ecovadis, FSSC 22000, NSF, FAMIQS, and HALAL. Management also highlighted a new R and D facility of Rs 25.3 crore completed in Oct 2025, intended to accelerate innovation and development of high-value products.

Balance sheet signals: deleveraging, cash flow improvement, and funded growth

Yasho’s management put emphasis on financial strength alongside growth. Debt-EBITDA ratio improved to 3.75 in FY26 from 4.70 in FY25. This does not mean leverage is low, but it shows directionally better capacity to service debt relative to earnings.

The company also reported prepayment of term liabilities: Rs 23.30 crore prepaid for FY27, leaving only Rs 15.60 crore due. That prepayment reduces near-term refinancing pressure and adds flexibility as the company steps into a higher capex cycle.

Cash flows also improved meaningfully in FY26. Net cash from operating activities was Rs 151.29 crore versus negative Rs 40.85 crore in FY25. This shift was driven by higher operating profit before working capital changes and a positive change in working capital in FY26 versus a large negative in FY25. Investing cash flow was negative Rs 72.56 crore, consistent with capex. Financing cash flow was negative Rs 81.20 crore.

On the balance sheet, total assets stood at Rs 1,155.06 crore in FY26 versus Rs 1,094.15 crore in FY25. Borrowings were split between non-current borrowings of Rs 289.13 crore and current borrowings of Rs 251.81 crore. Total equity stood at Rs 443.92 crore.

The near-term investor question is whether growth will force more leverage. Management’s stated plan is to avoid that. For FY26, of a total capex outlay of Rs 100 crore, the company utilized Rs 75 crore for R and D and two new manufacturing lines. For a strategic project with an MNC, the company received Rs 51.40 crore as of the date of the presentation. The company planned capex of Rs 125 crore, fully funded through internal accruals. Execution and cash conversion will determine how smoothly that plan plays out.

Strategic visibility: the MNC project and FY28 targets

One of the cleaner forward signals in the presentation is the customer-funded strategic manufacturing project secured with a large global MNC. Management described it as an Rs 85 to 90 crore customer-funded project initiated in Oct 2025, with Rs 51.4 crore advance received. Equipment delivery is expected to begin in Q1 FY27. Commercialization is expected in Q1 FY28.

This project structure matters because it de-risks capital intensity. Customer funding and an advance payment reduce working capital strain and add revenue visibility once commercialization begins. It also fits Yasho’s stated direction of partnering with multinational customers and moving up the specialty chemicals value chain.

Management also laid out explicit medium-term targets. The company aims for revenue of Rs 1,500 crore by FY28, EBITDA margin of more than 20 percent, and improved debt-EBITDA ratio. Alongside these, the company emphasized continuous launch of value-added and differentiated products.

These targets are ambitious relative to FY26 reported revenue of Rs 830.03 crore and EBITDA margin of 17.40 percent, but not disconnected from the levers management has identified: higher utilization, new lines scaling up, and the MNC project commercialization.

Takeaways for investors

Q4 FY26 was a strong quarter for Yasho Industries on scale and earnings, with revenue up 33 percent year on year and PAT up 144 percent. FY26 also marked a step-change in profitability and cash generation, despite an external environment that management described as disrupted by tariffs, geopolitics, and supply chain volatility.

The more important part of the story sits in what comes next. The company is building around three execution levers: lifting utilization from around 60 percent to above 75 percent, scaling two new manufacturing lines along with a newer R and D facility, and delivering a customer-funded MNC project expected to commercialize in Q1 FY28.

If these levers land as planned, the company’s FY28 goals of Rs 1,500 crore revenue and EBITDA margin above 20 percent look like a logical extension of the operating model rather than a stretch narrative. But the path runs through utilization discipline, margin recovery from better scale, and steady balance sheet management. FY26 ended with improved debt metrics and better operating cash flow, giving management a stronger base to execute.